PUBLISHER: Persistence Market Research | PRODUCT CODE: 1442682
PUBLISHER: Persistence Market Research | PRODUCT CODE: 1442682
Antibody Discovery Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2030
Persistence Market Research has recently published an extensive report on the global Antibody Discovery Market. The significant growth observed in this market underscores the increasing demand for innovative antibody-based therapeutics and diagnostics, driven by factors such as the rising prevalence of chronic and infectious diseases, advancements in biotechnology and immunology research, and the growing investments in drug discovery and development. The report highlights the pivotal role of antibody discovery technologies in accelerating the identification and optimization of therapeutic antibodies, thereby addressing unmet medical needs and improving patient outcomes.
The global antibody discovery market is forecast to expand at a CAGR of 8.9% and thereby increase from a value of US$7.53 Bn in 2023 to US$13.68 Bn by the end of 2030.
- Key Insights
Antibody Discovery Market Size (2023E): US$7.53 billion
Projected Market Value (2030F): US$13.68 billion
Global Market Growth Rate (CAGR 2023 to 2030): 8.9%
Historical Market Growth Rate (CAGR 2018 to 2022): 8.5%
Antibody Discovery Market - Report Scope
The Antibody Discovery Market report provides a comprehensive analysis of market dynamics, focusing on historical trends and future projections. Antibodies, also known as immunoglobulins, play a crucial role in immune responses and have emerged as versatile therapeutics and diagnostic tools for various diseases, including cancer, autoimmune disorders, infectious diseases, and inflammatory conditions. The report explores the nuances of the antibody discovery market, examining factors driving market growth, key market players, and emerging trends shaping the industry landscape.
Market Growth Drivers for Antibody Discovery Market:
The increasing prevalence of chronic diseases, such as cancer, autoimmune disorders, and cardiovascular diseases, has fueled the demand for targeted and personalized therapeutics, driving the adoption of antibody-based drugs and biologics. Monoclonal antibodies (mAbs) have gained prominence in the pharmaceutical industry due to their high specificity, efficacy, and safety profiles, making them ideal candidates for precision medicine approaches. Antibody discovery technologies, including hybridoma technology, phage display, transgenic animal platforms, and single-cell sequencing, enable the rapid identification and characterization of therapeutic antibody candidates, facilitating drug discovery and development processes.
Moreover, advancements in biotechnology and computational biology have revolutionized antibody discovery workflows, allowing for high-throughput screening, rational design, and optimization of antibody candidates with desired properties, such as binding affinity, specificity, and pharmacokinetics. The emergence of novel antibody formats, such as bispecific antibodies, antibody-drug conjugates (ADCs), and engineered antibody fragments, expands the therapeutic potential and clinical applications of antibody-based drugs, offering improved targeting, efficacy, and safety profiles. Additionally, the growing investments in antibody-based diagnostics, including immunoassays, biosensors, and point-of-care tests, contribute to market growth by enabling early disease detection, patient monitoring, and personalized treatment strategies.
- Market Restraints
Despite the promising prospects, the antibody discovery market faces challenges related to technological complexity, development costs, and intellectual property (IP) rights. Implementing and integrating advanced antibody discovery platforms and informatics solutions require specialized expertise, infrastructure, and resources, which may limit accessibility and adoption, particularly among smaller biotechnology and academic research organizations. Furthermore, the high cost and resource-intensive nature of antibody discovery and development processes, including target validation, lead optimization, and preclinical studies, pose financial constraints and risk management challenges for drug developers, impacting investment decisions and portfolio prioritization.
Intellectual property considerations, including patent exclusivity, licensing agreements, and freedom to operate, influence market competition, collaboration opportunities, and product commercialization strategies in the antibody discovery landscape. Patent thickets, overlapping IP rights, and legal disputes may hinder innovation and technology transfer, leading to market fragmentation and inefficiencies. Additionally, regulatory requirements for antibody-based therapeutics and diagnostics, including safety, efficacy, and manufacturing standards, impose compliance burdens and time-to-market delays, affecting product development timelines and market access.
- Market Opportunities
Amidst the challenges lie opportunities for innovation and market expansion within the antibody discovery market. Leveraging advances in genomics, proteomics, and artificial intelligence (AI) can accelerate target identification, antibody screening, and lead optimization processes, enhancing the efficiency and productivity of antibody discovery workflows. Integrated omics approaches, such as multiomics data analysis and predictive modeling, enable rational antibody design and personalized medicine strategies, facilitating the development of targeted therapies for specific patient populations and disease subtypes.
Furthermore, expanding applications of antibodies beyond traditional therapeutic and diagnostic domains, such as antibody-based theranostics, immunotherapy combinations, and precision agriculture, unlock new market opportunities and revenue streams. Collaborations and partnerships between academia, industry, and government agencies can foster technology transfer, knowledge exchange, and translational research initiatives, driving innovation and commercialization of antibody-based products. Moreover, leveraging emerging trends, such as cell-free protein synthesis, microfluidic screening platforms, and organ-on-a-chip models, can enhance the scalability, reproducibility, and cost-effectiveness of antibody discovery technologies, enabling broader access and adoption across diverse end-user segments.
Key Questions Answered in Report::
- What is the Forecast CAGR of the Antibody Discovery Market in 2030?
- What is the Global Market Size of Antibody Discovery as of the End of 2023?
- Which Region Dominated the Antibody Discovery Market in 2023?
- Who are the Key Players in the Global Antibody Discovery Market?
- Which Antibody Discovery Technologies Hold the Largest Opportunities for Market Integration?
Competitive Intelligence and Business Strategy
In navigating the competitive landscape, companies in the Antibody Discovery Market must leverage competitive intelligence and strategic business initiatives to differentiate themselves and capitalize on emerging opportunities. Understanding market dynamics, technological trends, and competitor strategies is essential for informed decision-making and market positioning.
Furthermore, investing in research and development, technology innovation, and strategic partnerships can help companies enhance their antibody discovery capabilities, expand their product portfolios, and strengthen their market presence. By focusing on collaboration, diversification, and customer-centric approaches, companies can drive innovation, accelerate product development timelines, and capture market share in the dynamic Antibody Discovery Market.
- Key Companies Profiled
- Alcami Corporation, Inc.
- BASF SE
- Bioduro-Sundia
- Bruker
- Cambrex Corporation
- Croda International Plc
Aragen Life Sciences Pvt. Ltd
Eurofins DiscoverX Corporation
- NanoCellect Biomedical
- Sartorius AG
Antibody Discovery Market Research Segmentation
Market segmentation based on Method, Antibody, end-user, and region provides valuable insights into key market segments and regional dynamics, enabling companies to tailor their offerings to specific customer needs and preferences. By understanding the unique requirements of different customer segments and geographic markets, companies can develop targeted strategies to address market demands effectively, thereby gaining a competitive edge and driving growth in the Antibody Discovery Market.
- By Method:
- Phage Display
- Hybridoma
- Others
- By Antibody Type:
- Humanized Antibody
- Human Antibody
- Chimeric Antibody
- Murine Antibody
- By End-use:
Pharmaceutical and Biotechnology industry
- Research laboratory
- Academic laboratory
- By Region:
- North America
- Europe
- East Asia
- South Asia & Oceania
- Latin America
- Middle East & Africa
Table of Contents
1. Executive Summary
- 1.1. Global Antibody Discovery Market Snapshot, 2023 and 2030
- 1.2. Market Opportunity Assessment, 2023 - 2030, US$ Mn
- 1.3. Key Market Trends
- 1.4. Future Market Projections
- 1.5. Premium Market Insights
- 1.6. Industry Developments and Key Market Events
- 1.7. PMR Analysis and Recommendations
2. Market Overview
- 2.1. Market Scope and Definition
- 2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Opportunity
- 2.2.4. Challenges
- 2.2.5. Key Trends
- 2.3. Method Lifecycle Analysis
- 2.4. Antibody Discovery Market: Value Chain
- 2.4.1. List of Raw Material Supplier
- 2.4.2. List of Manufacturers
- 2.4.3. List of Distributors
- 2.4.4. List of Applications
- 2.4.5. Profitability Analysis
- 2.5. Porter Five Force's Analysis
- 2.6. Geopolitical Tensions: Market Impact
- 2.7. Macro-Economic Factors
- 2.7.1. Global Sectorial Outlook
- 2.7.2. Global GDP Growth Outlook
- 2.7.3. Global Parent Market Overview
- 2.8. Forecast Factors - Relevance and Impact
- 2.9. Regulatory and Technology Landscape
3. Global Antibody Discovery Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
- 3.1. Key Highlights
- 3.1.1. Market Volume (Units) Projections
- 3.1.2. Market Size and Y-o-Y Growth
- 3.1.3. Absolute $ Opportunity
- 3.2. Market Size (US$ Mn) Analysis and Forecast
- 3.2.1. Historical Market Size Analysis, 2013-2016
- 3.2.2. Current Market Size Forecast, 2018-2026
- 3.3. Global Antibody Discovery Market Outlook: Method
- 3.3.1. Introduction / Key Findings
- 3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Method, 2018 - 2022
- 3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Method, 2023 - 2030
- 3.3.3.1. Phage Display
- 3.3.3.2. Hybridoma
- 3.3.3.3. Others
- 3.4. Market Attractiveness Analysis: Method
- 3.5. Global Antibody Discovery Market Outlook: Antibody Type
- 3.5.1. Introduction / Key Findings
- 3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Antibody Type, 2018 - 2022
- 3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Antibody Type, 2023 - 2030
- 3.5.3.1. Humanized Antibody
- 3.5.3.2. Human Antibody
- 3.5.3.3. Chimeric Antibody
- 3.5.3.4. Murine Antibody
- 3.6. Market Attractiveness Analysis: Antibody Type
- 3.7. Global Antibody Discovery Market Outlook: End User
- 3.7.1. Introduction / Key Findings
- 3.7.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By End User, 2018 - 2022
- 3.7.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 3.7.3.1. Pharmaceutical and Biotechnology industry
- 3.7.3.2. Research laboratory
- 3.7.3.3. Academic laboratory
- 3.8. Market Attractiveness Analysis: End User
4. Global Antibody Discovery Market Outlook: Region
- 4.1. Key Highlights
- 4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2018 - 2022
- 4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2023 - 2030
- 4.3.1. North America
- 4.3.2. Europe
- 4.3.3. East Asia
- 4.3.4. South Asia & Pacific
- 4.3.5. Latin America
- 4.3.6. Middle East & Africa (MEA)
- 4.4. Market Attractiveness Analysis: Region
5. North America Antibody Discovery Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
- 5.1. Key Highlights
- 5.2. Pricing Analysis
- 5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 5.3.1. By Country
- 5.3.2. By Method
- 5.3.3. By Antibody Type
- 5.3.4. By End User
- 5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 5.4.1. U.S.
- 5.4.2. Canada
- 5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Method, 2023 - 2030
- 5.5.1. Phage Display
- 5.5.2. Hybridoma
- 5.5.3. Others
- 5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Antibody Type, 2023 - 2030
- 5.6.1. Humanized Antibody
- 5.6.2. Human Antibody
- 5.6.3. Chimeric Antibody
- 5.6.4. Murine Antibody
- 5.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 5.7.1. Pharmaceutical and Biotechnology industry
- 5.7.2. Research laboratory
- 5.7.3. Academic laboratory
- 5.8. Market Attractiveness Analysis
6. Europe Antibody Discovery Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
- 6.1. Key Highlights
- 6.2. Pricing Analysis
- 6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 6.3.1. By Country
- 6.3.2. By Method
- 6.3.3. By Antibody Type
- 6.3.4. By End User
- 6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 6.4.1. Germany
- 6.4.2. France
- 6.4.3. U.K.
- 6.4.4. Italy
- 6.4.5. Spain
- 6.4.6. Russia
- 6.4.7. Turkey
- 6.4.8. Rest of Europe
- 6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Method, 2023 - 2030
- 6.5.1. Phage Display
- 6.5.2. Hybridoma
- 6.5.3. Others
- 6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Antibody Type, 2023 - 2030
- 6.6.1. Humanized Antibody
- 6.6.2. Human Antibody
- 6.6.3. Chimeric Antibody
- 6.6.4. Murine Antibody
- 6.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 6.7.1. Pharmaceutical and Biotechnology industry
- 6.7.2. Research laboratory
- 6.7.3. Academic laboratory
- 6.8. Market Attractiveness Analysis
7. East Asia Antibody Discovery Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
- 7.1. Key Highlights
- 7.2. Pricing Analysis
- 7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 7.3.1. By Country
- 7.3.2. By Method
- 7.3.3. By Antibody Type
- 7.3.4. By End User
- 7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 7.4.1. China
- 7.4.2. Japan
- 7.4.3. South Korea
- 7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Method, 2023 - 2030
- 7.5.1. Phage Display
- 7.5.2. Hybridoma
- 7.5.3. Others
- 7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Antibody Type, 2023 - 2030
- 7.6.1. Humanized Antibody
- 7.6.2. Human Antibody
- 7.6.3. Chimeric Antibody
- 7.6.4. Murine Antibody
- 7.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 7.7.1. Pharmaceutical and Biotechnology industry
- 7.7.2. Research laboratory
- 7.7.3. Academic laboratory
- 7.8. Market Attractiveness Analysis
8. South Asia & Oceania Antibody Discovery Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
- 8.1. Key Highlights
- 8.2. Pricing Analysis
- 8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 8.3.1. By Country
- 8.3.2. By Method
- 8.3.3. By Antibody Type
- 8.3.4. By End User
- 8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 8.4.1. India
- 8.4.2. Southeast Asia
- 8.4.3. ANZ
- 8.4.4. Rest of South Asia & Oceania
- 8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Method, 2023 - 2030
- 8.5.1. Phage Display
- 8.5.2. Hybridoma
- 8.5.3. Others
- 8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Antibody Type, 2023 - 2030
- 8.6.1. Humanized Antibody
- 8.6.2. Human Antibody
- 8.6.3. Chimeric Antibody
- 8.6.4. Murine Antibody
- 8.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 8.7.1. Pharmaceutical and Biotechnology industry
- 8.7.2. Research laboratory
- 8.7.3. Academic laboratory
- 8.8. Market Attractiveness Analysis
9. Latin America Antibody Discovery Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
- 9.1. Key Highlights
- 9.2. Pricing Analysis
- 9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 9.3.1. By Country
- 9.3.2. By Method
- 9.3.3. By Antibody Type
- 9.3.4. By End User
- 9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 9.4.1. Brazil
- 9.4.2. Mexico
- 9.4.3. Rest of Latin America
- 9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Method, 2023 - 2030
- 9.5.1. Phage Display
- 9.5.2. Hybridoma
- 9.5.3. Others
- 9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Antibody Type, 2023 - 2030
- 9.6.1. Humanized Antibody
- 9.6.2. Human Antibody
- 9.6.3. Chimeric Antibody
- 9.6.4. Murine Antibody
- 9.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 9.7.1. Pharmaceutical and Biotechnology industry
- 9.7.2. Research laboratory
- 9.7.3. Academic laboratory
- 9.8. Market Attractiveness Analysis
10. Middle East & Africa Antibody Discovery Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
- 10.1. Key Highlights
- 10.2. Pricing Analysis
- 10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 10.3.1. By Country
- 10.3.2. By Method
- 10.3.3. By Antibody Type
- 10.3.4. By End User
- 10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 10.4.1. GCC
- 10.4.2. Egypt
- 10.4.3. South Africa
- 10.4.4. Northern Africa
- 10.4.5. Rest of Middle East & Africa
- 10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Method, 2023 - 2030
- 10.5.1. Phage Display
- 10.5.2. Hybridoma
- 10.5.3. Others
- 10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Antibody Type, 2023 - 2030
- 10.6.1. Humanized Antibody
- 10.6.2. Human Antibody
- 10.6.3. Chimeric Antibody
- 10.6.4. Murine Antibody
- 10.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
- 10.7.1. Pharmaceutical and Biotechnology industry
- 10.7.2. Research laboratory
- 10.7.3. Academic laboratory
- 10.8. Market Attractiveness Analysis
11. Competition Landscape
- 11.1. Market Share Analysis, 2022
- 11.2. Market Structure
- 11.2.1. Competition Intensity Mapping By Market
- 11.2.2. Competition Hybridoma
- 11.2.3. Apparent Product Capacity
- 11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
- 11.3.1. Alcami Corporation, Inc.
- 11.3.1.1. Overview
- 11.3.1.2. Segments and Product
- 11.3.1.3. Key Financials
- 11.3.1.4. Market Developments
- 11.3.1.5. Market Strategy
- 11.3.2. BASF SE
- 11.3.2.1. Overview
- 11.3.2.2. Segments and Product
- 11.3.2.3. Key Financials
- 11.3.2.4. Market Developments
- 11.3.2.5. Market Strategy
- 11.3.3. Bioduro-Sundia
- 11.3.3.1. Overview
- 11.3.3.2. Segments and Product
- 11.3.3.3. Key Financials
- 11.3.3.4. Market Developments
- 11.3.3.5. Market Strategy
- 11.3.4. Bruker
- 11.3.4.1. Overview
- 11.3.4.2. Segments and Product
- 11.3.4.3. Key Financials
- 11.3.4.4. Market Developments
- 11.3.4.5. Market Strategy
- 11.3.5. Cambrex Corporation
- 11.3.5.1. Overview
- 11.3.5.2. Segments and Product
- 11.3.5.3. Key Financials
- 11.3.5.4. Market Developments
- 11.3.5.5. Market Strategy
- 11.3.6. Croda International Plc
- 11.3.6.1. Overview
- 11.3.6.2. Segments and Product
- 11.3.6.3. Key Financials
- 11.3.6.4. Market Developments
- 11.3.6.5. Market Strategy
- 11.3.7. Aragen Life Sciences Pvt. Ltd
- 11.3.7.1. Overview
- 11.3.7.2. Segments and Product
- 11.3.7.3. Key Financials
- 11.3.7.4. Market Developments
- 11.3.7.5. Market Strategy
- 11.3.8. Eurofins DiscoverX Corporation
- 11.3.8.1. Overview
- 11.3.8.2. Segments and Product
- 11.3.8.3. Key Financials
- 11.3.8.4. Market Developments
- 11.3.8.5. Market Strategy
- 11.3.9. NanoCellect Biomedical
- 11.3.9.1. Overview
- 11.3.9.2. Segments and Product
- 11.3.9.3. Key Financials
- 11.3.9.4. Market Developments
- 11.3.9.5. Market Strategy
- 11.3.10. Sartorius AG
- 11.3.10.1. Overview
- 11.3.10.2. Segments and Product
- 11.3.10.3. Key Financials
- 11.3.10.4. Market Developments
- 11.3.10.5. Market Strategy
- 11.3.1. Alcami Corporation, Inc.
12. Appendix
- 12.1. Research Methodology
- 12.2. Research Assumptions
- 12.3. Acronyms and Abbreviations
